Free Trial

InMed Pharmaceuticals (INM) SEC Filings & 10K Form

InMed Pharmaceuticals logo
$2.90 -0.15 (-4.92%)
Closing price 07/3/2025 03:51 PM Eastern
Extended Trading
$2.90 0.00 (0.00%)
As of 07/3/2025 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent InMed Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/24/2025
1:35 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2025
8:06 AM
InMed Pharmaceuticals (Filer)
Form DEFA14A
05/16/2025
4:15 PM
InMed Pharmaceuticals (Filer)
Form DEF 14A
05/13/2025
5:19 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
7:24 AM
InMed Pharmaceuticals (Filer)
Form PRE 14A
04/02/2025
3:13 PM
AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/14/2025
1:56 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
8:38 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
4:30 PM
InMed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/03/2025
10:20 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
7:49 AM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
9:18 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
9:54 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
10:46 AM
InMed Pharmaceuticals (Filer)
Form 424B3
01/01/2025
11:15 PM
InMed Pharmaceuticals (Filer)
Form EFFECT
12/30/2024
11:16 AM
InMed Pharmaceuticals (Filer)
Form S-1/A
12/23/2024
4:16 PM
InMed Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/23/2024
8:25 AM
InMed Pharmaceuticals (Issuer)
Lemerond Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:26 AM
InMed Pharmaceuticals (Issuer)
Jagpal Netta (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:28 AM
InMed Pharmaceuticals (Issuer)
Johnson Shane Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:17 AM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:18 AM
Baldasare Bryan T (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:20 AM
ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:21 AM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:22 AM
Grove Janet P (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:24 AM
InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
5:18 AM
InMed Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/19/2024
10:55 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:05 AM
InMed Pharmaceuticals (Subject)
YA II PN, Ltd. (Filed by)
Form SCHEDULE 13G
11/12/2024
12:44 PM
AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
Form SC 13G
11/05/2024
8:08 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:50 PM
InMed Pharmaceuticals (Filer)
Form DEF 14A
10/28/2024
3:00 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
2:25 PM
InMed Pharmaceuticals (Filer)
Form DEFA14A
10/24/2024
2:57 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
11:28 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
5:30 AM
InMed Pharmaceuticals (Filer)
Form 424B3
09/30/2024
12:37 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:10 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
1:04 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
1:00 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
White House to reset Social Security? (Ad)

Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.

And it could have a major impact on how you collect Social Security - Click here to understand what'
07/30/2024
2:08 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INM) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners